Exzellenz in der Bildung für eine innovative Schweiz: Die Position des Wirtschaftsdachverbandes Chemie Pharma Biotech

Abstract

In Switzerland, the chemical, pharma and biotech industries make a substantial and sustained contribution to the Swiss economy. The company members of scienceindustries employ around 70,000 people in Switzerland. Since 1980 value creation and productivity have increased markedly. As a result the share of the Swiss gross value added has grown continually to reach 5.6% in 2015. Exports have also increased. Today the chemical, pharma and biotech industry contributes around 45% of all Swiss exports and is therefore the largest Swiss export industry. This article describes the key requirements from the viewpoint of the chemical-pharma industry in order that Switzerland can continue to compete as an innovative location in global competition.